Get complete Patent Opposition Report for Galenicum Health Slu

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Galenicum Health Slu's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3512505Mar 15, 2023Vildagliptin Pharmaceutical Compositions2
EP3240529Feb 2, 2022Stable Pharmaceutical Compositions Comprising Micafungin2
EP2915526Jun 2, 2021Pharmaceutical Compositions Comprising Anagrelide1
EP3102187Mar 25, 2020Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets7